These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 38642067)
21. The Coming of Age of Nucleic Acid Vaccines during COVID-19. Rando HM; Lordan R; Kolla L; Sell E; Lee AJ; Wellhausen N; Naik A; Kamil JP; ; Gitter A; Greene CS mSystems; 2023 Apr; 8(2):e0092822. PubMed ID: 36861992 [TBL] [Abstract][Full Text] [Related]
22. People's Willingness to Vaccinate Against COVID-19 Despite Their Safety Concerns: Twitter Poll Analysis. Eibensteiner F; Ritschl V; Nawaz FA; Fazel SS; Tsagkaris C; Kulnik ST; Crutzen R; Klager E; Völkl-Kernstock S; Schaden E; Kletecka-Pulker M; Willschke H; Atanasov AG J Med Internet Res; 2021 Apr; 23(4):e28973. PubMed ID: 33872185 [TBL] [Abstract][Full Text] [Related]
23. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants. Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM Elife; 2022 Aug; 11():. PubMed ID: 36004719 [TBL] [Abstract][Full Text] [Related]
24. SHEA position statement on pandemic preparedness for policymakers: introduction and overview. Hsu VP; Haessler S; Banach DB; Batshon LJ; Branch-Elliman W; Dumyati G; Jump RLP; Malani AN; Mathew TA; Murthy RK; Pergam SA; Shenoy ES; Weber DJ Infect Control Hosp Epidemiol; 2024 Jul; 45(7):801-803. PubMed ID: 38835222 [TBL] [Abstract][Full Text] [Related]
25. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
26. Unraveling the Complexities of Severe Acute Respiratory Syndrome Coronavirus 2: A Comprehensive Ophthalmic and Systemic Perspective. Neri P; Perez Y; Agarwal A; Pichi F J Ocul Pharmacol Ther; 2024 Jun; 40(5):253-258. PubMed ID: 38669054 [TBL] [Abstract][Full Text] [Related]
27. [COVID-19: Warp Speed vaccines]. Feraoun Y; Maisonnasse P; Le Grand R; Beignon AS Med Sci (Paris); 2021; 37(8-9):759-772. PubMed ID: 34080537 [TBL] [Abstract][Full Text] [Related]
28. Addressing Parental Vaccine Hesitancy and Other Barriers to Childhood/Adolescent Vaccination Uptake During the Coronavirus (COVID-19) Pandemic. Olusanya OA; Bednarczyk RA; Davis RL; Shaban-Nejad A Front Immunol; 2021; 12():663074. PubMed ID: 33815424 [TBL] [Abstract][Full Text] [Related]
29. Global Health Needs Modernized Containment Strategies to Prepare for the Next Pandemic. Seetah K; Moots H; Pickel D; Van Cant M; Cianciosi A; Mordecai E; Cullen M; Maldonado Y Front Public Health; 2022; 10():834451. PubMed ID: 35769777 [TBL] [Abstract][Full Text] [Related]
30. COVID-19 and vaccination: myths vs science. Chavda VP; Chen Y; Dave J; Chen ZS; Chauhan SC; Yallapu MM; Uversky VN; Bezbaruah R; Patel S; Apostolopoulos V Expert Rev Vaccines; 2022 Nov; 21(11):1603-1620. PubMed ID: 35980281 [TBL] [Abstract][Full Text] [Related]
31. The Race for COVID-19 Vaccines: The Various Types and Their Strengths and Weaknesses. Muhar BK; Nehira J; Malhotra A; Kotchoni SO J Pharm Pract; 2023 Aug; 36(4):953-966. PubMed ID: 35723017 [TBL] [Abstract][Full Text] [Related]
32. Dynamic Evolution of SARS-CoV-2 in West Sumatra: Analyzing S Gene Mutations Across Variants and Their Impact on Public Health and Vaccine Strategies. Linosefa L; Hasmiwati H; Jamsari J; Putra AE Pak J Biol Sci; 2024 Mar; 27(4):182-189. PubMed ID: 38812109 [TBL] [Abstract][Full Text] [Related]
33. Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines. Zhu C; Pang S; Liu J; Duan Q Drugs; 2024 Apr; 84(4):403-423. PubMed ID: 38652356 [TBL] [Abstract][Full Text] [Related]
34. Global Emergence of SARS-CoV2 Infection and Scientific Interventions to Contain its Spread. Ajmera H; Lakhawat SS; Malik N; Kumar A; Bhatti JS; Kumar V; Gogoi H; Jaswal SK; Chandel S; Sharma PK Curr Protein Pept Sci; 2024; 25(4):307-325. PubMed ID: 38265408 [TBL] [Abstract][Full Text] [Related]
35. Promoting societal resilience during the COVID-19 pandemic: a multi-country analysis of public health strategies. D'Amelio AC; Cataldi S; Dallagiacoma G; Gentile L; Odone A; Signorelli C Acta Biomed; 2023 Aug; 94(S3):e2023181. PubMed ID: 37695174 [TBL] [Abstract][Full Text] [Related]
36. Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms. Aileni M; Rohela GK; Jogam P; Soujanya S; Zhang B Cells; 2022 Mar; 11(7):. PubMed ID: 35406746 [TBL] [Abstract][Full Text] [Related]
37. Advances in gene-based vaccine platforms to address the COVID-19 pandemic. Pushparajah D; Jimenez S; Wong S; Alattas H; Nafissi N; Slavcev RA Adv Drug Deliv Rev; 2021 Mar; 170():113-141. PubMed ID: 33422546 [TBL] [Abstract][Full Text] [Related]
38. Stopping pandemics before they start: Lessons learned from SARS-CoV-2. Edwards AM; Baric RS; Saphire EO; Ulmer JB Science; 2022 Mar; 375(6585):1133-1139. PubMed ID: 35271333 [TBL] [Abstract][Full Text] [Related]
39. Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm? Oh KB; Doherty TM; Vetter V; Bonanni P Expert Rev Vaccines; 2022 Nov; 21(11):1541-1553. PubMed ID: 36039786 [TBL] [Abstract][Full Text] [Related]
40. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021. Bui NN; Lin YT; Huang SH; Lin CW Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]